Olmesartan medoxomil and Abnormal behavior - a phase IV clinical study of FDA data

Summary:

Abnormal behavior is reported as a side effect among people who take Olmesartan medoxomil (olmesartan medoxomil), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Nifedipine, and have Dementia alzheimer's type.

The phase IV clinical study analyzes which people have Abnormal behavior when taking Olmesartan medoxomil. It is created by eHealthMe based on reports of 14,970 people who have side effects when taking Olmesartan medoxomil from the FDA, and is updated regularly.

What is Olmesartan medoxomil?

Olmesartan medoxomil has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 15,240 Olmesartan medoxomil users. Check the latest studies of Olmesartan medoxomil.

What is Abnormal behavior?

Abnormal behavior is found to be associated with 1,359 drugs and 1,957 conditions by eHealthMe. Check the latest studies of Abnormal behavior.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

14,970 people reported to have side effects when taking Olmesartan medoxomil.
Among them, 12 people (0.08%) have Abnormal behavior.

Could Olmesartan medoxomil cause Abnormal behavior?

Among these 12 people:

How long have people been on Olmesartan medoxomil when they have Abnormal behavior? *

What is the gender of people who have Abnormal behavior when taking Olmesartan medoxomil? *

female: 50 %
male: 50 %

What is the age of people who have Abnormal behavior when taking Olmesartan medoxomil? *

What are other drugs people take besides Olmesartan medoxomil? *

What are other side effects people have besides Abnormal behavior? *

Malaise (a feeling of general discomfort or uneasiness): 4 people, 33.33%
Loss Of Consciousness: 3 people, 25.00%
Confusional State: 3 people, 25.00%
Acute Kidney Failure: 3 people, 25.00%
Swallowing Difficulty: 3 people, 25.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 16.67%
Nosebleed (bleeding from nose): 2 people, 16.67%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 16.67%
Hypertensive Crisis: 2 people, 16.67%
Fall: 2 people, 16.67%

What are the existing conditions these people have? *

Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 5 people, 41.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Type 2 Diabetes: 1 person, 8.33%
Spinal Compression Fracture (fracture due to spinal compression on bone): 1 person, 8.33%
Renovascular Hypertension (a syndrome which consists of high blood pressure caused by the kidneys hormonal response): 1 person, 8.33%
Parkinson's Disease: 1 person, 8.33%
Pain: 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Olmesartan medoxomil and have Abnormal behavior?

- Check whether Abnormal behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Olmesartan medoxomil:

Olmesartan medoxomil (15,240 reports)

Browse all side effects of Olmesartan medoxomil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abnormal behavior:

Abnormal behavior (1,359 drugs)

Browse all the conditions that are associated with Abnormal behavior:

Abnormal behavior (1,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil (the active ingredients of Olmesartan medoxomil) and Olmesartan medoxomil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.